Teleflex (NYSE:TFX) Releases Quarterly Earnings Results, Beats Expectations By $0.09 EPS

Teleflex (NYSE:TFX) posted its quarterly earnings data on Thursday. The medical technology company reported $3.42 earnings per share for the quarter, topping the consensus estimate of $3.33 by $0.09, Briefing.com reports. Teleflex had a net margin of 9.82% and a return on equity of 14.78%. The company had revenue of $749.70 million during the quarter, compared to analysts’ expectations of $762.98 million. During the same period in the prior year, the company posted $3.41 earnings per share. Teleflex’s revenue for the quarter was up .9% compared to the same quarter last year. Teleflex updated its FY24 guidance to $13.80-14.20 EPS and its FY 2024 guidance to 13.800-14.200 EPS.

Teleflex Stock Up 0.5 %

Shares of TFX traded up $1.18 during trading hours on Friday, reaching $237.13. 743,641 shares of the stock traded hands, compared to its average volume of 373,837. The company has a current ratio of 2.51, a quick ratio of 1.41 and a debt-to-equity ratio of 0.37. The stock has a fifty day simple moving average of $213.52 and a 200 day simple moving average of $221.54. Teleflex has a 52 week low of $177.63 and a 52 week high of $257.85. The company has a market cap of $11.17 billion, a price-to-earnings ratio of 38.06, a PEG ratio of 2.14 and a beta of 1.13.

Teleflex Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Monday, September 16th. Investors of record on Thursday, August 15th will be given a dividend of $0.34 per share. This represents a $1.36 dividend on an annualized basis and a dividend yield of 0.57%. The ex-dividend date of this dividend is Thursday, August 15th. Teleflex’s payout ratio is currently 21.83%.

Analyst Upgrades and Downgrades

Several equities research analysts have recently weighed in on the stock. Truist Financial increased their price objective on shares of Teleflex from $235.00 to $240.00 and gave the stock a “hold” rating in a research report on Tuesday, July 16th. Piper Sandler raised shares of Teleflex from a “neutral” rating to an “overweight” rating and increased their target price for the stock from $205.00 to $245.00 in a research note on Monday, July 1st. Stephens increased their target price on shares of Teleflex from $275.00 to $290.00 and gave the stock an “overweight” rating in a research note on Friday. Royal Bank of Canada increased their target price on shares of Teleflex from $235.00 to $260.00 and gave the stock an “outperform” rating in a research note on Friday. Finally, Needham & Company LLC reissued a “hold” rating on shares of Teleflex in a research note on Friday, May 3rd. Three investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to MarketBeat.com, the company presently has an average rating of “Moderate Buy” and an average price target of $264.57.

Teleflex Company Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.